SGK1 and Myocardial fibrosis: In female db/db mice, empagliflozin improved diastolic function, reduce cardiomyocyte cross-sectional area, myocardial fibrosis, and pro-fibrotic SGK1/ENaC protein expression levels but not blood pressure or dipping status23.